Hill Dickinson advised Sativa Group plc on the deal.
Sativa Group, the UK’s leading quoted CBD wellness and medicinal cannabis group, made a recommended share-for-share offer by Stillcanna Inc. The transaction represents the first public takeover by a Canadian-listed entity of a UK company operating in the medical cannabis sector.
The merger of Sativa Group and Stillcanna will create a fully integrated ‘seed to consumer’ CBD wellness group.
Since its initial admission to AQSE, Sativa Group completed a series of acquisitions moving from being an investment company to the holding company operating five separate businesses in the CBD wellness sector, including the operation of online and physical retail stores selling CBD products, analytical hemp and CBD testing, and the distribution and manufacturing of THC medicinal cannabis for research purposes.
Stillcanna Inc, a Canadian company listed on the Canadian Securities Exchange (CSE), whose securities are also quoted on the OTC in the United States and the Open Market of the Frankfurt Stock Exchange, is a leader in cannabinoid extraction and agriculture that is focused on the large-scale manufacturing of CBD in Europe. It has built two high-volume extraction facilities, positioning itself as a leader in seed to CBD supply.
The Hill Dickinson team advising Sativa Group plc on the takeover was led by senior associate Sam Hudson and partner Shantanu Sinha (Picture), with assistance from associates Laura Scott and Paul Jackson. In addition, senior associate Jack Delaney and associate Natalia Fryda provided regulatory advice in connection with the admission of the enlarged group’s shares to trading on AQSE.